Despite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.
Eric Berberian, PharmD candidate
Advertisement
Articles by Eric Berberian, PharmD candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Zilganersen Injection, First Drug for Alexander Disease
2
New CKD Outcome Set Tells Pharmacists What to Measure
3
New Lipid Drugs and What Pharmacists Need to Know
4
AAP Issue 2026-2027 Guidance on RSV and COVID-19 Immunization
5